Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-02-14

Clinical Trial Update: Study of Non-inferiority Between Manzanilla Sophia® and Meticel Ofteno® 0.5% for Providing a Soothing Sensation to the Eyes. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Manzanilla Sophia and Meticel Ofteno 0.5% for soothing the eyes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Manzanilla Sophia
  • Meticel Ofteno 0.5%

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Eye Strain, Eye Strain of Both Eyes | Phase 4 | Status: WITHDRAWN